Author:
Schneeberger A.,Goos M.,Stingl G.,Wagner S. N.
Publisher
Springer Berlin Heidelberg
Reference153 articles.
1. Abdel-Wahab Z, Weltz C, Hester D, Pickett N, Vervaert C, Barber JR, Jolly D, Seigier HF (1997) A phase I trial of immunotherapy with interferon-y gene-modified autologous melanoma cells. Cancer 80:401–412
2. Akslen LA, Monstad SE, Larsen B, Straume O, Ogreid D (1998) Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer 79:91–95
3. Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, Andreeff M (1989) Analysis of the ras oncogenes in malignant melanoma and precursor lesion: Correlation of point mutations with differentiation phenotype. Oncogene 4:1363–1374
4. Albino AP, Sozzi G, Nanus DM, Jhanwar SC, Houghton AN (1992) Malignant transformation of human melanocytes: induction of a complete phenotype and genotype. Oncogene 7:3415–3421
5. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK (1994) Mutation and expression of the p53 in human malignant melanoma. Melanoma Research 4:35–45